MATRx plus

The MATRx plus is a ventilatory effort recorder designed for use in home and hospital settings to assist in the diagnosis of sleep disordered breathing in adults by capturing physiological signals including respiratory airflow, oximetry, effort, and body position. Employing a patient-worn recorder, a dual-lumen nasal cannula for enhanced airflow sensing, and wireless data transmission to a tablet and secure portal, the device furnishes raw data and a calculated Oxygen Desaturation Index to support clinical assessment.

The MATRx plus system, from Zephyr Sleep Technologies, is engineered to aid healthcare professionals in diagnosing and assessing sleep disordered breathing in adult patients. This portable, battery-operated device is intended for supervised use in both home and hospital environments. It records key physiological data during sleep, including respiratory nasal airflow via a dual-lumen cannula that samples each naris independently, snoring levels, blood oxygen saturation, pulse rate, respiratory effort using an inductance-based belt, and body position. The system architecture includes a recorder worn on the patient's abdomen, associated sensors, and a bedside tablet for user interaction and initial data handling. During a sleep study, the MATRx plus recorder wirelessly transmits the collected physiological data via Bluetooth to the bedside tablet. This tablet not only guides the patient through the study setup but also provides feedback on whether sufficient data has been captured. Following the study, the data is automatically uploaded to a secure online portal, allowing healthcare professionals to access and download it to a Data Viewer application. This application then generates a comprehensive report containing both recorded and analyzed data, specifically highlighting metrics like the Oxygen Desaturation Index (ODI), average, minimum, and maximum oxygen saturation, and pulse rate statistics. Notably, while the MATRx plus provides detailed raw data for thorough clinical review, it does not independently calculate or report Apnea-Hypopnea Index (AHI) or specific apnea/hypopnea event classifications; its ODI autoscoring algorithm's performance was validated using data from 179 patients, and overall device functionality was confirmed through bench testing.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the dual-lumen nasal cannula, sampling pressure from each naris independently, improve the accuracy of airflow measurement and snore detection compared to single-lumen cannulas, particularly in cases of unilateral nasal obstruction?; Given that the MATRx plus system does not automatically calculate AHI, RI, or classify apnea/hypopnea events, what is the typical workflow for clinicians to derive these critical diagnostic parameters from the raw data provided, and how does this impact diagnostic efficiency?; What were the specific outcomes of the ODI autoscoring algorithm validation against the Snore SAT monitor using data from 179 patients, particularly regarding sensitivity, specificity, and any observed biases?; How does the wireless data transmission to a bedside tablet and subsequent upload to a secure portal enhance patient compliance and data integrity compared to devices requiring manual data extraction via USB?; Considering the device uses an inductance principle for respiratory effort and samples at 25 Hz, what is its comparative sensitivity in detecting subtle respiratory effort variations, such as respiratory effort-related arousals (RERAs), when compared to traditional polysomnography effort sensors?